FORTE BIOSCIENCES, INC. Paid-in-Kind Interest
FORTE BIOSCIENCES, INC. (FBRX) reported Paid-in-Kind Interest of $654.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-04-23.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2020-04-23
- FORTE BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2020-03-31 was $654.00K, a 360.56% increase year-over-year.
- FORTE BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2019-12-31 was $57.00K, a 60.69% decline year-over-year.
- FORTE BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2019-09-30 was $1.35M, a 847.55% increase year-over-year.
- FORTE BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2019-06-30 was $144.00K, a 80.17% decline year-over-year.
- FORTE BIOSCIENCES, INC. paid-in-kind interest for fiscal 2019 was $1.70M, a 46.25% increase from fiscal 2018.
- FORTE BIOSCIENCES, INC. paid-in-kind interest for fiscal 2018 was $1.16M, a 96.78% increase from fiscal 2017.
- FORTE BIOSCIENCES, INC. paid-in-kind interest for fiscal 2017 was $590.00K, a 3.51% increase from fiscal 2016.
- FORTE BIOSCIENCES, INC. paid-in-kind interest for fiscal 2016 was $570.00K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2020-03-31 | $654.00K 10-Q · filed 2020-04-23 | $711.00K derived: sum of 2 quarters · filed 2020-04-23 | $2.07M derived: sum of 3 quarters · filed 2020-04-23 | $2.21M derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.41M derived: sum of 2 quarters · filed 2020-02-27 | $1.56M derived: sum of 3 quarters · filed 2020-02-27 | $1.70M 10-K · filed 2020-02-27 |
| 2019-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.50M derived: sum of 2 quarters · filed 2019-11-12 | $1.64M 10-Q · filed 2019-11-12 | $1.79M derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $286.00K 10-Q · filed 2019-08-08 | $431.00K derived: sum of 3 quarters · filed 2020-04-23 | $574.00K derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-03-31 | $142.00K 10-Q · filed 2020-04-23 | $287.00K derived: sum of 2 quarters · filed 2020-04-23 | $430.00K derived: sum of 3 quarters · filed 2020-04-23 | $1.16M derived: sum of 4 quarters · filed 2020-04-23 |
| 2018-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $288.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.01M derived: sum of 3 quarters · filed 2020-02-27 | $1.16M 10-K · filed 2020-02-27 |
| 2018-09-30 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $869.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.02M 10-Q · filed 2019-11-12 | $1.17M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $726.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $873.00K 10-Q · filed 2019-08-08 | $1.02M derived: sum of 3 quarters · filed 2020-02-27 | $1.17M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $147.00K 10-Q · filed 2019-05-07 | $296.00K derived: sum of 2 quarters · filed 2020-02-27 | $444.00K derived: sum of 3 quarters · filed 2020-02-27 | $590.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $297.00K derived: sum of 2 quarters · filed 2020-02-27 | $443.00K derived: sum of 3 quarters · filed 2020-02-27 | $590.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $294.00K derived: sum of 2 quarters · filed 2018-11-08 | $441.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $293.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $147.00K 10-Q · filed 2018-05-11 | |||
| 2016-12-31 | $570.00K 10-K · filed 2019-02-27 |